| Jason Browder, PA-C | |
|
660 Golden Ridge Rd, Ste. 250, Golden, CO 80401-9541 | |
| (303) 233-1223 | |
| (303) 233-8755 |
| Full Name | Jason Browder |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 11 Years |
| Location | 660 Golden Ridge Rd, Golden, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134544240 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 3923 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Montrose Memorial Hospital | Montrose, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Montrose Memorial Hospital Inc | 1658272992 | 61 |
News Archive
The CDC's opioid prescribing guideline has failed to reduce addiction and overdoses, significantly worsened the quality of pain care in the United States and should be revoked, according to a large new survey of patients and healthcare providers by Pain News Network, an independent, non-profit news organization.
A new Harris Interactive phone survey conducted among 1,000 allergy sufferers, 1,000 consumers (both allergy sufferers and non-sufferers) and 300 physicians shows that beyond the sneezing, sniffling and watery eyes, allergies also have deep and emotional impacts on a sufferer's mood and self-perceptions.
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet needs, primarily in the treatment of neurodegenerative diseases, announced today the Company has achieved last patient out in two studies: a Phase 1 clinical study of NP001 in patients with Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease) and a Phase 1/2 clinical study of NP002 in patients with L-dopa-induced dyskinesias (muscle movement disorders).
Bausch + Lomb, a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX), today announced that its next generation sub-micron gel formulation of loteprednol etabonate was statistically superior to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery by study day eight, the primary endpoints in the first Phase 3, multi-center, double-masked, vehicle-controlled, parallel-group study.
An emotionally intelligent, partially autonomous social robot could help children with autism spectrum disorder improve their social skills, according to EU-funded researchers who have been developing the next generation of robot-enhanced therapy.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jason Browder, PA-C 660 Golden Ridge Rd, Ste. 250, Golden, CO 80401-9541 Ph: (303) 233-1223 | Jason Browder, PA-C 660 Golden Ridge Rd, Ste. 250, Golden, CO 80401-9541 Ph: (303) 233-1223 |
News Archive
The CDC's opioid prescribing guideline has failed to reduce addiction and overdoses, significantly worsened the quality of pain care in the United States and should be revoked, according to a large new survey of patients and healthcare providers by Pain News Network, an independent, non-profit news organization.
A new Harris Interactive phone survey conducted among 1,000 allergy sufferers, 1,000 consumers (both allergy sufferers and non-sufferers) and 300 physicians shows that beyond the sneezing, sniffling and watery eyes, allergies also have deep and emotional impacts on a sufferer's mood and self-perceptions.
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet needs, primarily in the treatment of neurodegenerative diseases, announced today the Company has achieved last patient out in two studies: a Phase 1 clinical study of NP001 in patients with Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease) and a Phase 1/2 clinical study of NP002 in patients with L-dopa-induced dyskinesias (muscle movement disorders).
Bausch + Lomb, a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX), today announced that its next generation sub-micron gel formulation of loteprednol etabonate was statistically superior to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery by study day eight, the primary endpoints in the first Phase 3, multi-center, double-masked, vehicle-controlled, parallel-group study.
An emotionally intelligent, partially autonomous social robot could help children with autism spectrum disorder improve their social skills, according to EU-funded researchers who have been developing the next generation of robot-enhanced therapy.
› Verified 1 days ago
Sadie Thomas, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 660 Golden Ridge Rd Ste 250, Golden, CO 80401 Phone: 303-233-1223 | |
Erin George Walker Cole, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5920 Mcintyre St, Golden, CO 80403 Phone: 303-949-1250 | |
Mr. Travis John Neill, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5920 Mcintyre St, #300, Golden, CO 80403 Phone: 720-434-4876 | |
Mrs. Allison Ann Villegas, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 5920 Mcintyre St, Golden, CO 80403 Phone: 303-949-1250 | |
Nicholas E. Walsh, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 660 Golden Ridge Rd, Suite 250, Golden, CO 80401 Phone: 303-233-1223 | |
Jessica J Barber, PA C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 660 Golden Ridge Rd, Suite 250, Golden, CO 80401 Phone: 303-233-1223 Fax: 303-233-8755 | |
Ms. Hannah Sarah Strauss, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 660 Golden Ridge Rd Ste 250, Golden, CO 80401 Phone: 303-233-1223 Fax: 303-233-8755 |